The global scleral lens market was valued at USD 301.84 million in 2023 and is anticipated to grow to USD 712.50 million by 2032, registering a robust CAGR of 10.01% during 2024-2032. This growth is primarily driven by the rising prevalence of corneal disorders, the adoption of innovative fitting technologies, and increasing awareness about the therapeutic benefits of scleral lenses for complex ocular conditions.
Scleral lenses are specialized contact lenses that vault over the cornea and rest on the sclera, providing superior comfort, visual acuity, and tear retention, especially for patients with keratoconus, post-surgical complications, or severe dry eye syndrome. Market trends indicate a growing preference for mini-scleral lenses due to their optimal size, comfort, and ease of fitting, making them increasingly popular among eye care professionals and patients alike.
U.S. Leads Global Scleral Lens Market
The U.S. dominated the scleral lens market in 2023 with a market size of USD 100.93 million and is projected to reach USD 244.97 million by 2032, growing at a CAGR of 10.35%. The country’s stronghold is supported by advanced healthcare infrastructure, widespread adoption of innovative vision correction technologies, and a growing prevalence of ocular surface disorders.
A significant factor behind U.S. market dominance is the high number of certified ophthalmologists and optometrists trained in specialty lens fittings, enabling greater patient access. Additionally, the presence of specialty lens laboratories and key market players fosters continuous innovation in custom-designed scleral lenses. Reimbursement policies from Medicare and private insurers further enhance patient affordability and adoption.
Growing awareness regarding the therapeutic advantages of scleral lenses for complex corneal conditions has also contributed to the rising demand, reinforcing the U.S. as a market leader.
Unveil Market Trends: Get Your Sample Report Now: https://www.snsinsider.com/sample-request/3028
Market Drivers
Rising Prevalence of Corneal Disorders and Ocular Surface Diseases
The increasing incidence of keratoconus, dry eye syndrome, and post-surgical complications is a major growth driver. According to the National Eye Institute, keratoconus affects approximately 1 in 2,000 individuals in the U.S., while millions suffer from chronic dry eye conditions. Scleral lenses provide superior optical correction and comfort compared to conventional lenses by maintaining a reservoir of tears and vaulting over the cornea.
Surging clinical awareness and advances in patient education, fitting technologies, and diagnostic tools are driving adoption across both developed and emerging healthcare markets. Ophthalmologists increasingly recommend scleral lenses as a primary solution for complex corneal conditions, further bolstering market growth.
Market Restraints
High Customization Costs and Limited Reimbursement
Despite clinical benefits, scleral lenses are significantly more expensive than standard contact lenses, costing between USD 1,000 and USD 3,000 per pair, excluding follow-up and consultation fees. Limited reimbursement frameworks in many regions, particularly in Asia and parts of Europe, restrict patient affordability and market penetration.
Additionally, the need for trained specialists to perform fittings raises adoption costs, creating financial hurdles for patients and smaller clinics. Addressing affordability challenges remains crucial for sustainable market growth globally.
Emerging Opportunities
Integration of Topography-guided Fitting Technologies and 3D Printing
Advanced imaging technologies such as optical coherence tomography (OCT), profilometry, and corneal topography have revolutionized the fitting process, enabling precise customization for patients with complex corneal geometries. The integration of 3D printing in scleral lens manufacturing allows for faster prototyping, cost-effective production, and ultra-customized lenses.
Major market participants are investing heavily in automated lens design software and AI-powered diagnostic systems, streamlining fitting processes. The increasing adoption of these technologies among ophthalmologists and optometrists enhances accessibility and efficiency, creating opportunities for market expansion in previously underserved regions.
Key Challenges
Shortage of Skilled Professionals
Fitting scleral lenses requires specialized expertise, particularly for patients with complex corneal conditions. Globally, there is a shortage of trained eye care professionals proficient in scleral lens fittings. According to the Scleral Lens Education Society, only a small fraction of optometrists in emerging markets possess this expertise, resulting in inconsistent patient outcomes and limited market penetration.
The steep learning curve and investment in diagnostic equipment may discourage smaller clinics from offering scleral lens services, posing a challenge for global market expansion.
Market Segmentation
By Type
Mini-scleral lenses, ranging from 15 mm to 18 mm in diameter, accounted for 69% of the global market in 2023. Their optimal balance of comfort, ease of fitting, and oxygen permeability makes them highly preferred among both new wearers and clinicians. Mini-scleral lenses require less fluid to fill the vault and reduce hypoxia risk, offering superior visual correction and stability.
By Application
Eye clinics led the market with a 38% share in 2023 due to advanced diagnostic tools and skilled ophthalmologists and optometrists specializing in complex fittings. These clinics provide continuous and personalized care, crucial for follow-ups and multiple fittings. Hospitals and other healthcare facilities are also adopting scleral lenses but remain secondary to dedicated eye care centers.
Regional Insights
North America
North America held a 44% share of the global scleral lens market in 2023, driven by advanced healthcare infrastructure, rapid adoption of ophthalmic technologies, and strong networks of certified eye care professionals. Supportive reimbursement policies and the presence of major innovators in the region enhance market penetration.
Asia Pacific
The Asia Pacific region is witnessing rapid growth due to increasing awareness of advanced eye care solutions, rising prevalence of vision disorders, and growing disposable income. Countries including South Korea, India, China, and Japan are investing in urban eye clinics, modern diagnostic tools, and local manufacturing networks, contributing to increasing demand.
Key Players
Art Optical Contact Lens Inc, Blanchard Lab, Bausch Health Companies Inc., CooperVision, Acculens, TruForm Optics Inc., BostonSight, ABB Optical Group, Essilor, Optact International Ltd., Valley Contax Inc., SynergEyes, Visionary Optics, Scanoptics, Advanced Vision Technologies, X-Cel Specialty Contacts, AccuLens Specialty Contact Lenses, LCS Labs, EyePrint Prosthetics, Innovative Sclerals
Recent Developments
In October 2023, Alcon introduced TOTAL30 Multifocal, the first monthly contact lens featuring Water Gradient technology for multifocal users, improving all-day comfort and vision correction. In February 2023, Visionary Optics launched the Europa Tangent, a scleral lens with a three-zone step system for highly customizable and precise fitting.
Future Outlook
The scleral lens market is poised for substantial growth, driven by advancements in topography-guided fittings, 3D printing, AI-based diagnostic tools, and rising global prevalence of corneal disorders. Expanding the pool of trained professionals and improving reimbursement policies will be critical for market sustainability and accessibility.
Conclusion
Rising ocular surface disorders, technological innovations, and increasing awareness are set to drive the global scleral lens market to USD 712.50 million by 2032. With mini-scleral lenses and advanced eye clinics leading adoption, the market is positioned for robust expansion across North America, Asia Pacific, and emerging regions, offering improved vision care solutions for patients worldwide.
Other Trending Reports
